D. P. Ryan, C. C. Compton, and R. J. Mayer, Carcinoma of the anal canal, N. Engl. J. Med, vol.342, pp.792-800, 2000.

M. Fesneau, E. Champeaux-orange, and C. Hennequin,

, Cancer Radiother. J. Soc. Fr. Radiother. Oncol, pp.120-126, 2010.

R. Glynne-jones and A. Renehan, Current treatment of anal squamous cell carcinoma, Hematol. Oncol. Clin. North Am, vol.26, pp.1315-1350, 2012.

R. Glynne-jones, P. J. Nilsson, C. Aschele, V. Goh, D. Peiffert et al., Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.25, pp.10-20, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01799935

L. Moureau-zabotto, V. Vendrely, L. Abramowitz, C. Borg, E. Francois et al., Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up, vol.49, pp.831-840, 2017.

J. Papillon, M. Mayer, J. F. Montbarbon, J. P. Gerard, J. L. Chassard et al., A new approach to the management of epidermoid carcinoma of the anal canal, Cancer, vol.51, pp.1830-1837, 1983.

, Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin, Lancet Lond. Engl, vol.348, pp.1049-1054, 1996.

H. Bartelink, F. Roelofsen, F. Eschwege, P. Rougier, J. F. Bosset et al., Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.15, pp.2040-2049, 1997.

J. A. Ajani, K. A. Winter, L. L. Gunderson, J. Pedersen, A. B. Benson et al., Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial, JAMA, vol.299, 1914.

R. Sadeghi, S. Harsini, M. A. Qodsi-rad, V. R. Dabbagh, and G. Treglia, Prognostic Significance of Fluorine-18

, Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis, Contrast Media Mol. Imaging, p.9760492, 2018.

J. Papillon and J. F. Montbarbon, Epidermoid carcinoma of the anal canal. A series of 276 cases, Dis. Colon Rectum, vol.30, pp.324-333, 1987.

M. Schlienger, C. Krzisch, F. Pene, J. L. Marin, B. Gindrey-vie et al., Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases, Int. J. Radiat. Oncol. Biol. Phys, vol.17, pp.1141-1151, 1989.

J. P. Wagner, M. A. Mahe, P. Romestaing, F. P. Rocher, C. Berger et al., Radiation therapy in the conservative treatment of carcinoma of the anal canal, Int. J. Radiat. Oncol. Biol. Phys, vol.29, pp.17-23, 1994.

J. A. Ajani, K. A. Winter, L. L. Gunderson, J. Pedersen, A. B. Benson et al., Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: The intergroup trial (RTOG 98-11), Cancer, vol.116, pp.4007-4013, 2010.

R. Glynne-jones, D. Sebag-montefiore, R. Adams, S. Gollins, M. Harrison et al., United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial Working Party. Prognostic factors for recurrence and survival in anal cancer: Generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I), Cancer, vol.119, pp.748-755, 2013.

, Fédération Nationale des Centres de Lutte Contre le Cancer Enquête Permanente Cancer, Monographie FNCLCC, 1975.

R. J. Salmon, J. Fenton, B. Asselain, G. Mathieu, J. Girodet et al., Treatment of epidermoid anal canal cancer, Am. J. Surg, vol.147, pp.43-48, 1984.

L. L. Gunderson, J. Moughan, J. A. Ajani, J. E. Pedersen, K. A. Winter et al., Anal carcinoma: Impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial, Int. J. Radiat. Oncol. Biol. Phys, vol.87, pp.638-645, 2013.

J. Sveistrup, A. Loft, A. K. Berthelsen, B. M. Henriksen, M. B. Nielsen et al., Positron emission tomography/computed tomography in the staging and treatment of anal cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.83, pp.134-141, 2012.

J. G. Bazan, A. C. Koong, D. S. Kapp, A. Quon, E. E. Graves et al., Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.54, pp.27-32, 2013.

N. J. Bhuva, R. Glynne-jones, L. Sonoda, W. Wong, and M. K. Harrison, To PET or not to PET? That is the question. Staging in anal cancer, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.23, pp.2078-2082, 2012.

S. E. Cotter, P. W. Grigsby, B. A. Siegel, F. Dehdashti, R. S. Malyapa et al., FDG-PET/CT in the evaluation of anal carcinoma, Int. J. Radiat. Oncol. Biol. Phys, vol.65, pp.720-725, 2006.

B. T. Nguyen, D. L. Joon, V. Khoo, G. Quong, M. Chao et al., Assessing the impact of FDG-PET in the management of anal cancer, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.87, pp.376-382, 2008.

E. De-winton, A. G. Heriot, M. Ng, R. J. Hicks, A. Hogg et al., The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, Br. J. Cancer, vol.100, pp.693-700, 2009.

M. Mistrangelo, E. Pelosi, M. Bellò, U. Ricardi, E. Milanesi et al., Role of positron emission tomography-computed tomography in the management of anal cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.84, pp.66-72, 2012.

L. Vercellino, F. Montravers, V. De-parades, V. Huchet, K. Kerrou et al., Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma, Int. J. Colorectal Dis, vol.26, pp.201-210, 2011.

A. Mahmud, R. Poon, and D. Jonker, PET imaging in anal canal cancer: A systematic review and meta-analysis, Br. J. Radiol, vol.90, 2017.

M. Gauthé, M. Richard-molard, J. Fayard, J. Alberini, W. Cacheux et al., Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer, Eur. J. Nucl. Med. Mol. Imaging, vol.44, pp.63-70, 2017.

L. Deantonio, M. E. Milia, T. Cena, G. Sacchetti, C. Perotti et al., Anal cancer FDG-PET standard uptake value: Correlation with tumor characteristics, treatment response and survival, Radiol. Med, vol.121, pp.54-59, 2016.

E. A. Kidd, F. Dehdashti, B. A. Siegel, and P. W. Grigsby, Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.95, pp.288-291, 2010.

M. Shali, S. Schmitt, V. Behrendt, F. F. Winz, O. H. Heinzel et al., Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival, Eur. J. Radiol, vol.85, pp.1390-1394, 2016.

F. L. Day, E. Link, S. Ngan, T. Leong, K. Moodie et al., FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy, Br. J. Cancer, vol.105, pp.498-504, 2011.

E. Rusten, B. L. Rekstad, C. Undseth, D. Klotz, E. Hernes et al., Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors, Br. J. Radiol, vol.92, 2019.

A. Duimering, T. Riauka, Y. Nijjar, S. Ghosh, R. Macewan et al., Prognostic utility of pre-and post-treatment FDG-PET parameters in anal squamous cell carcinoma, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.136, pp.21-28, 2019.

S. Vauclin, K. Doyeux, S. Hapdey, A. Edet-sanson, P. Vera et al., Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: Application to the comparison of three thresholding models, Phys. Med. Biol, vol.54, pp.6901-6916, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00467195

Y. E. Erdi, O. Mawlawi, S. M. Larson, M. Imbriaco, H. Yeung et al., Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding, Cancer, vol.80, pp.2505-2509, 1997.

Q. C. Black, I. S. Grills, L. L. Kestin, C. O. Wong, J. W. Wong et al., Defining a radiotherapy target with positron emission tomography, Int. J. Radiat. Oncol. Biol. Phys, vol.60, pp.1272-1282, 2004.

U. Nestle, S. Kremp, A. Schaefer-schuler, C. Sebastian-welsch, D. Hellwig et al., Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.46, pp.1342-1348, 2005.

S. Vauclin, I. Gardin, K. Doyeux, S. Hapdey, A. Edet-sanson et al., Segmentation des images TEP au 18 F-FDG. Principe et revue de la littérature, Méd. Nucl, vol.34, pp.358-369, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00475873

M. B. Amin, S. Edge, F. Greene, D. R. Byrd, R. K. Brookland et al., AJCC Cancer Staging Manual, 2017.

J. A. Lee, Segmentation of positron emission tomography images: Some recommendations for target delineation in radiation oncology, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.96, pp.302-307, 2010.

A. Le-maitre, M. Hatt, O. Pradier, C. Cheze-le-rest, and D. Visvikis, Impact of the accuracy of automatic tumour functional volume delineation on radiotherapy treatment planning, Phys. Med. Biol, vol.57, pp.5381-5397, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00749029

D. Visvikis, M. Hatt, and F. Tixier, Cheze Le Rest, C. The age of reason for FDG PET image-derived indices, Eur. J. Nucl. Med. Mol. Imaging, vol.39, pp.1670-1672, 2012.

P. J. Brown, J. Zhong, R. Frood, S. Currie, A. Gilbert et al., Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT, Eur. J. Nucl. Med. Mol. Imaging, vol.46, pp.2790-2799, 2019.

M. Jones, G. Hruby, M. Solomon, N. Rutherford, and J. Martin, The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis, Ann. Surg. Oncol, vol.22, pp.3574-3581, 2015.

A. B. Benson, J. P. Arnoletti, T. Bekaii-saab, E. Chan, Y. Chen et al., Anal Carcinoma, Version 2.2012: Featured updates to the NCCN guidelines, J. Natl. Compr. Cancer Netw. JNCCN, vol.10, pp.449-454, 2012.